Weak Q1 masks strong order book; margin recovery unproven

Q1 revenue down 28% YoY; order book execution only INR21 Cr (4.9%) of INR430 Cr order

Export licenses just received past week; still awaiting importing country approvals; Katepally water trials expected September

Capacity exists but execution at 4.9% in Q1 (21/430); need 136 Cr/quarter average remaining vs 21 Cr Q1

No detailed recovery mechanism; raw materials not normalizing; price reset depends on completing old contracts first

INR1,393 Cr exists but only 102.6 Cr (7.4%) realized in Q1; 1,569 Cr prior guidance, now declined to 1,393 Cr (-130 Cr)

15-20% EBIT margin target now viewed as aspirational; 4.7% Q1 actual with no detailed recovery plan contradicts prior track record

Only 4.9% of ₹430 Cr order done in Q1; prior guidance implied faster execution; management now acknowledging export licensing delays

Several licenses received past week (prior quarter had ₹400 Cr pending); management now optimistic on Q2/Q3 dispatch acceleration

INR9-10 Cr sustainable (prior quarters had one-time provisions and forex losses); June 2025 also INR9 Cr.

Margins will definitely improve with product bouquet dispatch timing; historical 15-20% EBIT guidance remains target.

Partnering with drone manufacturers for payloads (not developing drones); participating as partner with suppliers.

Hoping association helps strategically; full potential clarity by December only.

Several licenses received past week; materials moving out; targeting ₹150-200 Cr in Q2.

LD still in process, completion by Oct-Nov; flares order backlog ₹75 Cr, completion in 4-5 months.

Q1 only ₹21 Cr; expecting better in Q2; claiming capability to complete entire order in FY27.

Yes, retaining guidance; yes, have capacity (flares own plant, chaffs depend on imports).

Considerable progress; DRDO/ARDE/HEMRL conducting tests; expects 6 more months for completion.

RDX/HMX integration almost complete; water trials September; mixing plant dummy trials end-September (components delayed by maritime, now air shipment).

Land pricing was issue; requested govt for reasonable price; currently on hold for renegotiation.

Apollo's strength in defense electronics; can integrate with energetic materials/high-energy systems; more details by next quarter.

Can only give industrial explosives (6%) vs defense (94%) breakup; cannot disclose program detail.

QRSAM tenders not yet called; no current participation.

Already have ₹1,393 Cr; expecting ₹200-300 Cr more inflow; all orders for next 2 years; expecting ₹1,000+ Cr annual run rate.

Export orders (maritime delays) and imported countermeasure components delayed; expecting to overcome in Q2.

Delays in getting export licenses (most now received); will complete Q2/Q3; not customer procurement delays.

Targeting ₹600 Cr, considerable increase vs prior 2 years.

License in process; typically 3-4 months processing; need importing country import license first; expecting some dispatch Q4.

Difficult to predict FY28 due to raw material dependence and 40+ players in field; FY27 ₹25-30 Cr Singareni balance remaining.

~₹80 Cr expected (like last year); margins very thin, many places negative (vs Coal India withdrawn due to low prices).

Demand good but licensing difficult; pricing depends on country; present war scenario pushed prices up, may change in 2-3 years; declined to quantify pricing bands (competitive).

Product mix bouquet variation and dispatch timing; yearly target remains 15-20%.

Vague: 'the difference what you're seeing is that'; claims will make up in coming quarters.

Not normalizing; have contracts to execute at old prices; once complete, will increase prices.

Right, for this financial year (ambiguous phrasing on whether applies to FY27 or longer term).

Expecting ₹500-600 Cr run rate; targeting ₹600 Cr FY27.

Q1 only ₹102.6 Cr; need ₹497 Cr in balance 9M (55 Cr/month avg); large orders (₹430 Cr Oct-25, ₹350 Cr Apr-26) not converting (only 4.9% and 0% in Q1). Feasibility hinge on export licensing acceleration and order dispatch execution.

Q1 actual 4.7% EBIT margin; 10-15 point gap to guidance unexplained in detail. CFO cites product mix and raw material costs but offers no bridge timeline. Recovery contingent on price renegotiation once old contracts complete.

RDX/HMX production expected to start post-Sep water trials (Oct onwards); mixing plant dummy trials end-Sep. Delays cited (maritime component issues) but now pushing air shipment. Timing slippage risk remains.

EBIT margin collapsed from 15-20% guidance to 4.7% Q1 (10-15 point miss). Raw material costs cited as temporary but not normalizing per CFO. Recovery depends on completing old contracts then renegotiating new ones.

Q1 execution only ₹102.6 Cr (7.4% of ₹1,393 Cr backlog). Large orders (₹430 Cr Oct-25, ₹350 Cr Apr-26) have only 4.9% and 0% completion. Need 55-60 Cr/month average for remaining 9M to hit ₹600 Cr guidance vs 34 Cr/month Q1.

₹350 Cr Apr-26 order awaiting export license approval (3-4 months typical) and importing country import license (both pre-requisites). Dispatch expected Q4 but approval timeline unclear.

Elevated raw material costs impacting margins; not normalizing per CFO. Chaffs/payloads depend on imports (maritime delays seen). Geopolitical volatility cited as current demand driver but also a supply risk.

Katepally expansion (RDX/HMX production) water trials Sep, mixing plant dummy trials end-Sep. Commissioning and production ramp timing uncertain. Maritime delays already cited for component imports; risk of further slippage.

94% of order book from Defense segment (₹1,309 Cr of ₹1,393 Cr). Concentrated customer base and execution dependent on government order processing timelines. Order book down from ₹1,569 Cr guidance.